Why Singaporeans are waiting hours at A&E — and what hospitals want you to do instead
CGH and SKH advised the public via Facebook yesterday to visit their EDs only for serious or life-threatening conditions, and to consult general practitioners or polyclinics for minor symptoms such as cough, sore throat or runny nose, The Straits Times reported.
KTPH, which began seeing a spike in ED cases after the recent long weekend, said the rise was not mainly due to Covid-19, despite a small increase in infections.
Health authorities said on May 13 that while there has been a rise in Covid-19 cases, current variants do not appear more transmissible or severe than earlier strains.
At 5.30pm on May 14, KTPH's website listed a wait time of 107 minutes with 135 patients in queue, dropping to 71 minutes and 124 patients by 6.30pm.
KTPH said its emergency department remains fully operational and under control, and that patients with critical conditions will still be seen immediately.
The Straits Times reported that during its visit to CGH yesterday, a notice outside the A&E department warned of waits lasting at least five to eight hours due to the surge in patients.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Dr. Jennifer Ashton and Dr. Joseph Woo join American Heart Association Board of Directors
(NewMediaWire) - July 16, 2025 - DALLAS The American Heart Association, the world's leading nonprofit organization focused on heart and brain health for all, announces the appointment of two leading health and science leaders, Jennifer Ashton, M.D., M.S. and Joseph Woo, M.D., FAHA, to its volunteer Board of Directors, effective July 1, 2025. Dr. Ashton and Dr. Woo bring clinical leadership, health media influence and scientific innovation to the Association as it enters its second century, intensifying its efforts to change the future of health and improve cardiovascular and cerebrovascular health outcomes, which continue to be leading causes of death in the United States. Double board-certified in Ob-Gyn and obesity medicine, Dr. Jennifer Ashton is a nationally recognized women's health advocate known for communicating complex medical topics in an accessible way. As ABC News' Chief Medical Correspondent, she became a nationally trusted voice during major public health events, including the COVID-19 pandemic. A Columbia duPont and Emmy Award-winning journalist, a bestselling author and champion of preventive health and mental wellness, Dr. Ashton has volunteered with the American Heart Association for more than a decade, frequently speaking at local Go Red for Women(R) events. She has received numerous honors from the Association, including the 2024 Heart Saver Hero Award, the 2023 "Woman Changing the World Award" and the Go Red for Women Award in 2018. These accolades reflect her tireless advocacy for women's cardiovascular health and her leadership in advancing the Association's mission through education and action. "As the obesity and maternal mortality epidemics are two of the most pressing issues affecting women in the U.S., and since both have cardiovascular associations, I hope that my experience and expertise in these fields can assist the American Heart Association's efforts," Ashton said. "And, as the daughter of a cardiologist, I am honored to be the first OB-GYN appointed to the Board in the history of the Association." As a board-certified cardiothoracic surgeon, cardiovascular surgeon and transplant surgeon, Dr. Joseph Woo is a nationally recognized leader and educator in cardiac surgery innovation. He is professor and chair of the Stanford Medicine Department of Cardiothoracic Surgery, associate director of the Stanford Cardiovascular Institute and the Norman E. Shumway Professor of Cardiothoracic Surgery. He has pioneered advanced surgical research on multiple studies and clinical trials, including numerous National Institutes of Health (NIH) grant projects, as well as American Heart Association grants to study ways to treat heart failure through cellular repair. In 2021, he received the Association's Clinical Research Prize for his groundbreaking work in minimally invasive heart valve repair. Earlier in his career, he received the Vivien Thomas Young Investigator Award (1997) for postdoctoral research on molecular strategies to reduce myocardial ischemic injury. Dr. Woo holds patents for several heart-related medical devices and surgical techniques and has co-authored over 490 peer-reviewed papers. Beyond his research, he is deeply committed to mentorship, global collaboration and advancing medical education in cardiovascular health. "As a physician-scientist, I have been a daily witness to the tragedy of cardiovascular disease on human life, and also to the triumph of improving health and saving lives through scientific discovery," Woo said. "The American Heart Association is a global leader in supporting vital research and establishing the best evidenced-based approaches to cardiovascular health and treatment grounded in basic science, engineering, translational and clinical investigation. I look forward to continuing to support the Association as we continue our bold endeavors toward a healthier world for all." "We are honored to welcome Dr. Jen Ashton and Dr. Joe Woo to our Board of Directors," said Nancy Brown, CEO of the American Heart Association. "Dr. Ashton's national media profile, influence and dedication to preventive health, alongside Dr. Woo's groundbreaking work in cardiovascular surgery and academic leadership, uniquely position them to help us change the future of health and drive forward our mission. Their perspectives will be instrumental as we continue our work to bring health and hope to everyone, everywhere." These appointments reflect the American Heart Association's continued commitment to science-based solutions, community-centered approaches and bold leadership in the fight against heart disease and stroke. The American Heart Association's Board of Directors is the organization's top volunteer governing body, working closely with CEO Nancy Brown to provide strategic oversight and financial stewardship to advance the organization's mission of longer, healthier lives for all. Board members also serve as ambassadors, leveraging their individual professional expertise and networks of influence to further extend, accelerate and elevate the Association's visibility, impact and collaborations. Additional Resources Multimedia is available on the right column of release link. Learn more about the American Heart Association's 2025-26 volunteer and staff leadership. Follow AHA/ASA news on X @HeartNews ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173 Suzanne Grant: For Public Inquiries: 1-800-AHA-USA1 (242-8721) and Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Associated Press
3 hours ago
- Associated Press
Dr. Jennifer Ashton and Dr. Joseph Woo join American Heart Association Board of Directors
( NewMediaWire ) - July 16, 2025 - DALLAS — The American Heart Association, the world's leading nonprofit organization focused on heart and brain health for all, announces the appointment of two leading health and science leaders, Jennifer Ashton, M.D., M.S. and Joseph Woo, M.D., FAHA, to its volunteer Board of Directors, effective July 1, 2025. Dr. Ashton and Dr. Woo bring clinical leadership, health media influence and scientific innovation to the Association as it enters its second century, intensifying its efforts to change the future of health and improve cardiovascular and cerebrovascular health outcomes, which continue to be leading causes of death in the United States. Double board-certified in Ob-Gyn and obesity medicine, Dr. Jennifer Ashton is a nationally recognized women's health advocate known for communicating complex medical topics in an accessible way. As ABC News' Chief Medical Correspondent, she became a nationally trusted voice during major public health events, including the COVID-19 pandemic. A Columbia duPont and Emmy Award-winning journalist, a bestselling author and champion of preventive health and mental wellness, Dr. Ashton has volunteered with the American Heart Association for more than a decade, frequently speaking at local Go Red for Women(R) events. She has received numerous honors from the Association, including the 2024 Heart Saver Hero Award, the 2023 ' Woman Changing the World Award ' and the Go Red for Women Award in 2018. These accolades reflect her tireless advocacy for women's cardiovascular health and her leadership in advancing the Association's mission through education and action. 'As the obesity and maternal mortality epidemics are two of the most pressing issues affecting women in the U.S., and since both have cardiovascular associations, I hope that my experience and expertise in these fields can assist the American Heart Association's efforts,' Ashton said. 'And, as the daughter of a cardiologist, I am honored to be the first OB-GYN appointed to the Board in the history of the Association.' As a board-certified cardiothoracic surgeon, cardiovascular surgeon and transplant surgeon, Dr. Joseph Woo is a nationally recognized leader and educator in cardiac surgery innovation. He is professor and chair of the Stanford Medicine Department of Cardiothoracic Surgery, associate director of the Stanford Cardiovascular Institute and the Norman E. Shumway Professor of Cardiothoracic Surgery. He has pioneered advanced surgical research on multiple studies and clinical trials, including numerous National Institutes of Health (NIH) grant projects, as well as American Heart Association grants to study ways to treat heart failure through cellular repair. In 2021, he received the Association's Clinical Research Prize for his groundbreaking work in minimally invasive heart valve repair. Earlier in his career, he received the Vivien Thomas Young Investigator Award (1997) for postdoctoral research on molecular strategies to reduce myocardial ischemic injury. Dr. Woo holds patents for several heart-related medical devices and surgical techniques and has co-authored over 490 peer-reviewed papers. Beyond his research, he is deeply committed to mentorship, global collaboration and advancing medical education in cardiovascular health. 'As a physician-scientist, I have been a daily witness to the tragedy of cardiovascular disease on human life, and also to the triumph of improving health and saving lives through scientific discovery,' Woo said. 'The American Heart Association is a global leader in supporting vital research and establishing the best evidenced-based approaches to cardiovascular health and treatment grounded in basic science, engineering, translational and clinical investigation. I look forward to continuing to support the Association as we continue our bold endeavors toward a healthier world for all.' 'We are honored to welcome Dr. Jen Ashton and Dr. Joe Woo to our Board of Directors,' said Nancy Brown, CEO of the American Heart Association. 'Dr. Ashton's national media profile, influence and dedication to preventive health, alongside Dr. Woo's groundbreaking work in cardiovascular surgery and academic leadership, uniquely position them to help us change the future of health and drive forward our mission. Their perspectives will be instrumental as we continue our work to bring health and hope to everyone, everywhere.' These appointments reflect the American Heart Association's continued commitment to science-based solutions, community-centered approaches and bold leadership in the fight against heart disease and stroke. The American Heart Association's Board of Directors is the organization's top volunteer governing body, working closely with CEO Nancy Brown to provide strategic oversight and financial stewardship to advance the organization's mission of longer, healthier lives for all. Board members also serve as ambassadors, leveraging their individual professional expertise and networks of influence to further extend, accelerate and elevate the Association's visibility, impact and collaborations. Additional Resources ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173 Suzanne Grant: [email protected] For Public Inquiries: 1-800-AHA-USA1 (242-8721) and


The Hill
3 hours ago
- The Hill
No link found between aluminum in vaccines and autism: Study
(NewsNation) — A new study out of Denmark challenges claims that aluminum in childhood vaccines poses health risks. Researchers analyzed the health records of more than 1.2 million children over a 24-year period. The study, published Monday in the Annals of Internal Medicine, found no evidence linking aluminum exposure from vaccines to any increase in chronic conditions such as asthma, autism, or autoimmune diseases. Aluminum salts are commonly used in vaccines as adjuvants to enhance immune response, according to the Children's Hospital of Philadelphia. COVID-19 cases surge in half of US, particularly South and West While critics have long raised concerns about the potential health hazards of aluminum, the study found no association between vaccine-related aluminum and any of the 50 chronic conditions examined, including 36 autoimmune disorders, nine conditions related to allergies or asthma and five neurodevelopmental disorders. Researchers used Denmark's nationwide registry to track vaccine history and medical outcomes for children born between 1997 and 2018, following them through the end of 2020. Researchers assessed aluminum exposure by age 2 and compared outcomes across varying exposure levels. The study didn't include unvaccinated children. Only 1.2 percent of children received no 'aluminum-adsorbed vaccines' before age 2. The rest received varying doses, with total aluminum exposure ranging from 0.125 mg to 1.00 mg per dose. The median exposure across the cohort was approximately 3 mg.